BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Myriad Genetics, Inc. To Announce Financial Results For The Second Quarter Of Fiscal Year 2014 On Tuesday February 4, 2014

  January 24, 2014

   · 

  1 min read
• Drug Development

  Infinity Pharmaceuticals Inc. Reports Phase 1 Data Of IPI-145 At Sixth Annual T-Cell Lymphoma Forum

  January 24, 2014

   · 

  1 min read
• Business

  Theravance, Inc. Appoints Frank Pasqualone Senior Vice President, Operations

  January 24, 2014

   · 

  4 min read
• Drug Development

  Inhibitor Program Acquired For Promising Research Of Rare Disease, Friedreich’s Ataxia

  January 24, 2014

   · 

  2 min read
• Deals

  Valeant Pharmaceuticals International Completes Acquisition Of Solta Medical, Inc.

  January 24, 2014

   · 

  3 min read
• Biotech Beach

  Adamis Pharmaceuticals Receives Notice Of Key Allowance For US Patent That Supports Its Cancer Immunology Portfolio

  January 24, 2014

   · 

  5 min read
• Ranbaxy Laboratories Drops A Little More As The FDA Bans More Products

  January 24, 2014

   · 

  1 min read
• Deals

  PharmaCell BV To Purchase Cell Therapy Production Facility From TiGenix

  January 24, 2014

   · 

  2 min read
• Pharm Country

  Akers Biosciences, Inc. Announces Pricing Of Public Offering Of Common Stock And Listing On NASDAQ

  January 24, 2014

   · 

  1 min read
• Business

  Vision-Sciences, Inc. to Host Third Quarter Fiscal 2014 Results Call

  January 24, 2014

   · 

  1 min read